Amgen Hits New Record High Amid Strong Operating Performance

Amgen (NASDAQ:AMGN), a global biotechnology company, has reached a fresh record high as its strong operating performance and diversified medicines support its recent momentum.

The company's diversified portfolio gives it several sources of commercial activity, reducing dependence on a single medicine and helping stabilize its broader business profile.

Amgen's quarterly update provided additional support for the recent share-price momentum, with revenue exceeding broad market expectations due to healthy demand across its commercial portfolio.